Tech Company Financing Transactions

HERVolution Therapeutics Funding Round

HERVolution Therapeutics, based in Copenhagen, secured $11.7 million in investment from Serum Institute of India, European Innovation Council Fund and private investors.

Transaction Overview

Announced On
12/19/2024
Transaction Type
Venture Equity
Amount
$11,700,000
Round
Series A
Proceeds Purpose
The company intends to use the funds to support key activities, including further validating and demonstrating the value of its human endogenous retroviruses (HERV)-targeting approach, cGMP manufacturing in collaboration with SII, initiating Phase 1 studies of its lead asset, investigating indication expansion opportunities, and expanding company infrastructure to support clinical trials.

Company Information

Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Undisclosed
Copenhagen, Undisclosed
Denmark
Phone
Undisclosed
Email Address
Not Recorded
Overview
HERVolution Therapeutics, a Copenhagen, Denmark-based dark genome-focused biotechnology company.
Profile
HERVolution Therapeutics LinkedIn Company Profile
Social Media
HERVolution Therapeutics Company Twitter Account
Company News
HERVolution Therapeutics News
Facebook
HERVolution Therapeutics on Facebook
YouTube
HERVolution Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Robert Coleman
  Robert Coleman LinkedIn Profile  Robert Coleman Twitter Account  Robert Coleman News  Robert Coleman on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/19/2024: Aiwyn venture capital transaction
Next: 12/19/2024: Anysphere venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary